The Eighth Annual International Employment Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Eighth Annual International Employment Survey


Pharmaceutical Technology


For some people, the statistics say it all: a growing salary, good benefits, daily intellectual challenges, and job security. Others gain a better perspective by looking closely at more subjective issues such as job environment, communication, and support from management.

Pharmaceutical Technology's 2005 employment report presents both sides. Thanks to the more than 2100 survey participants (our highest response yet), we highlight the issues directly affecting workers in the pharmaceutical industry, including demographic information, education and work experience, salary and benefits, and attitudes toward current employment. New this year, the survey portrays the effects on industry jobs of several federal guidelines and initiatives, and employees had an opportunity to sound off about the greatest satisfactions and frustrations of their work.


Table I: Results overview—profile of a typical industry employee.
Most results are representative of all responses, regardless of participants' locations. Some salary results are presented for US employees only. When reviewing salary and benefits information, readers should take into account a region's cost of living and economy as well as the wide range of experience, job functions, and educational certification represented. No single statistic should be used for comparison without taking these factors into account.

Methodology and statistics

The September 2005 questionnaire, posted on http://www.pharmtech.com/, received 2178 responses. Of these, 79% were received from industry workers in the United States, including Puerto Rico. Some overall results are summarized in Table I, with details provided in this article.

Demographics


Figure 1: Survey participants by sex.
Sex and age. Of the total number of responses, 70% overall were from men (see Figure 1). The average respondent age is 43 years.

Work location. As noted, 79% of respondents work in the United States. Of these, approximately 10% each work in California and New Jersey; 7% in Pennsylvania; 5% each in New York, North Carolina, and Massachusetts; 4% each in Illinois and Indiana; and ~2.5% each in Michigan and Puerto Rico. All other states each accounted for less than 2% of the total US responses.

Workers also responded from the United Kingdom (4%), Canada (3.4%), and Ireland (1.4%) as well as Germany, India, Italy, Belgium, The Netherlands, and Switzerland (~1% each). Other regions represented less than 1% each of the total number of responses.




Readers should take into account the number of responses received from each region when noting the results of this survey, especially salary results according to US region.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
21%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
8%
Regulatory compliance
42%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here